Eisenhauer EA , Therasse P , Bogaerts J , Schwartz LH , Sargent D , Ford R , et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228 -47. doi: 10.1016/j.ejca.2008.10.026. 18. European Medicine Agency . Guideline on the evaluation of anticancer medicinal products in man. EMA/CHMP/205/95/rev.4 December 2011. [Accessed 19 July 2015]. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/01/WC5 00137128.pdf 19. Fehrenbacher L , Spira A , Ballinger M , Kowanetz M , Vansteenkiste J , Mazieres J , et al. Atezolizumab versus docetaxel for patients with previously treated non -small -cell lung can cer (POPLAR): a multicentre, open -label, phase 2 randomised controlled trial. Lancet.